About 6,560,000 results
Open links in new tab
ECTRIMS 2024: Tolebrutinib may target smoldering inflammation
AB Science provides an update on the development of masitinib in ...
ECTRIMS Conference 2024 | Copenhagen 18-20 September | ECTRIMS
ECTRIMS 2024: Mavenclad sustains benefits in relapsing MS
ECTRIMS 2024: MS relapse rates fall with 5 years on Briumvi
The Effect of High- Vs Low- to Medium-Efficacy Treatments on …
ECTRIMS - European Committee for Treatment and Research in …
Immunic Presents Key Vidofludimus Calcium Data at the 40th
MSMilan 2023 - HOME | ECTRIMS
ECTRIMS 2024 - Medscape